-
1
-
-
0028987127
-
The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus
-
discussion 405-396
-
Holmberg SD, Buchbinder SP, Conley LJ, et al. The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus. Am J Epidemiol 1995;141:395- 404; discussion 405-396.
-
(1995)
Am J Epidemiol
, vol.141
, pp. 395-404
-
-
Holmberg, S.D.1
Buchbinder, S.P.2
Conley, L.J.3
-
2
-
-
37149046282
-
Frequency of seizures and epilepsy in neurological HIV-infected patients
-
DOI 10.1016/j.seizure.2007.05.017, PII S1059131107001306
-
Kellinghaus C, Engbring C, Kovac S, et al. Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure 2008;17:27-33. (Pubitemid 350256998)
-
(2008)
Seizure
, vol.17
, Issue.1
, pp. 27-33
-
-
Kellinghaus, C.1
Engbring, C.2
Kovac, S.3
Moddel, G.4
Boesebeck, F.5
Fischera, M.6
Anneken, K.7
Klonne, K.8
Reichelt, D.9
Evers, S.10
Husstedt, I.W.11
-
3
-
-
0025358253
-
Seizures in human immunodeficiency virus infection
-
Wong MC, Suite ND, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol 1990;47:640-642. (Pubitemid 20183570)
-
(1990)
Archives of Neurology
, vol.47
, Issue.6
, pp. 640-642
-
-
Wong, M.C.1
Suite, N.D.A.2
Labar, D.R.3
-
4
-
-
0242279419
-
Initial burden of disease estimates for South Africa, 2000
-
Bradshaw D, Groenewald P, Laubscher R, et al. Initial burden of disease estimates for South Africa, 2000. S Afr Med J 2003;93:682- 688.
-
(2003)
S Afr Med J
, vol.93
, pp. 682-688
-
-
Bradshaw, D.1
Groenewald, P.2
Laubscher, R.3
-
7
-
-
33846081438
-
Tuberculosis and HIV co-infection: A practical therapeutic approach
-
Breen RA, Swaden L, Ballinger J, Lipman MC. Tuberculosis and HIV co-infection: a practical therapeutic approach. Drugs 2006;66:2299 -2308.
-
(2006)
Drugs
, vol.66
, pp. 2299-2308
-
-
Breen, R.A.1
Swaden, L.2
Ballinger, J.3
Lipman, M.C.4
-
8
-
-
24344436865
-
Drugdrug interactions and tolerance in combining antituberculosis and antiretroviral therapy
-
Di Perri G, Aguilar Marucco D, Mondo A, et al. Drugdrug interactions and tolerance in combining antituberculosis and antiretroviral therapy. Expert Opin Drug Saf 2005;4:821- 836.
-
(2005)
Expert Opin Drug Saf
, vol.4
, pp. 821-836
-
-
Di Perri, G.1
Aguilar Marucco, D.2
Mondo, A.3
-
10
-
-
34547801743
-
Epilepsy and HIV: A dangerous combination
-
Epilepsy and HIV: a dangerous combination. Lancet Neurol 2007;6:747.
-
(2007)
Lancet Neurol
, vol.6
, pp. 747
-
-
-
11
-
-
34447319373
-
Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa
-
Birbeck G, Chomba E, Ddumba E, Kauye F, Mielke J. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa. Epilepsia 2007;48:1424 -1425.
-
(2007)
Epilepsia
, vol.48
, pp. 1424-1425
-
-
Birbeck, G.1
Chomba, E.2
Ddumba, E.3
Kauye, F.4
Mielke, J.5
-
12
-
-
33646066147
-
-
American Academy of Neurology. St. Paul, MN: American Academy of Neurology
-
American Academy of Neurology. Clinical Practice Guideline Process Manual: 2004 Edition. St. Paul, MN: American Academy of Neurology; 2005.
-
(2005)
Clinical Practice Guideline Process Manual: 2004 Edition
-
-
-
13
-
-
0024370706
-
New-onset seizures associated with human immunodeficiency virus infection: Causation and clinical features in 100 cases
-
Holtzman DM, Kaku DA, So YT. New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med 1989;87:173-177. (Pubitemid 19201638)
-
(1989)
American Journal of Medicine
, vol.87
, Issue.2
, pp. 173-177
-
-
Holtzman, D.M.1
Kaku, D.A.2
So, Y.T.3
-
14
-
-
0032890732
-
Prospective study of new-onset seizures in patients with human immunodeficiency virus infection: Etiologic and clinical aspects
-
DOI 10.1001/archneur.56.5.609
-
Pascual-Sedano B, Iranzo A, Marti-Fabregas J, et al. Prospective study of new-onset seizures in patients with human immunodeficiency virus infection: etiologic and clinical aspects. Arch Neurol 1999;56:609-612. (Pubitemid 29218157)
-
(1999)
Archives of Neurology
, vol.56
, Issue.5
, pp. 609-612
-
-
Pascual-Sedano, B.1
Iranzo, A.2
Marti-Fabregas, J.3
Domingo, P.4
Escartin, A.5
Fuster, M.6
Barrio, J.L.7
Sambeat, M.A.8
-
15
-
-
65349158551
-
Antiretroviral adherence in rural Zambia: The first year of treatment availability
-
Birbeck GL, Chomba E, Kvalsund M, et al. Antiretroviral adherence in rural Zambia: the first year of treatment availability. Am J Trop Med Hyg 2009;80:669-674.
-
(2009)
Am J Trop Med Hyg
, vol.80
, pp. 669-674
-
-
Birbeck, G.L.1
Chomba, E.2
Kvalsund, M.3
-
16
-
-
0034115247
-
Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals
-
DOI 10.1097/00002030-200003310-00017
-
Breen RA, Lipman MC, Johnson MA. Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals. AIDS 2000;14:615. (Pubitemid 30209704)
-
(2000)
AIDS
, vol.14
, Issue.5
, pp. 615
-
-
Breen, R.A.M.1
Lipman, M.C.I.2
Johnson, M.A.3
-
17
-
-
0037172861
-
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy
-
Schifitto G, McDermott MP, McArthur JC, et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002;58:1764 -1768.
-
(2002)
Neurology
, vol.58
, pp. 1764-1768
-
-
Schifitto, G.1
McDermott, M.P.2
McArthur, J.C.3
-
18
-
-
33745663308
-
HIV neuropathy natural history cohort study: Assessment measures and risk factors
-
Simpson DM, Kitch D, Evans SR, et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 2006;66:1679 -1687.
-
(2006)
Neurology
, vol.66
, pp. 1679-1687
-
-
Simpson, D.M.1
Kitch, D.2
Evans, S.R.3
-
19
-
-
77952121864
-
Continued high prevalence and adverse clinical impact of human immuno-deficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: The CHARTER Study
-
Ellis RJ, Rosario D, Clifford DB, et al. Continued high prevalence and adverse clinical impact of human immuno-deficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol 67:552-558.
-
Arch Neurol
, vol.67
, pp. 552-558
-
-
Ellis, R.J.1
Rosario, D.2
Clifford, D.B.3
-
20
-
-
56549121559
-
The effect of atazanavir and atazanavir/ritonavir on UDPglucuronosyltransferase using lamotrigine as a phenotypic probe
-
Burger DM, Huisman A, Van Ewijk N, et al. The effect of atazanavir and atazanavir/ritonavir on UDPglucuronosyltransferase using lamotrigine as a phenotypic probe. Clin Pharmacol Ther 2008;84:698 -703.
-
(2008)
Clin Pharmacol Ther
, vol.84
, pp. 698-703
-
-
Burger, D.M.1
Huisman, A.2
Van Ewijk, N.3
-
21
-
-
70349496064
-
The effect of raltegravir on the glucuronidation of lamotrigine
-
van Luin M, Colbers A, Verwey-van Wissen CP, et al. The effect of raltegravir on the glucuronidation of lamotrigine. J Clin Pharmacol 2009;49:1220 -1227.
-
(2009)
J Clin Pharmacol
, vol.49
, pp. 1220-1227
-
-
Van Luin, M.1
Colbers, A.2
Verwey-van Wissen, C.P.3
-
22
-
-
38349182976
-
Lack of a pharmacokinetic effect of raltegravir on midazolam: In vitro/in vivo correlation
-
Iwamoto M, Kassahun K, Troyer MD, et al. Lack of a pharmacokinetic effect of raltegravir on midazolam: in vitro/in vivo correlation. J Clin Pharmacol 2008;48:209-214.
-
(2008)
J Clin Pharmacol
, vol.48
, pp. 209-214
-
-
Iwamoto, M.1
Kassahun, K.2
Troyer, M.D.3
-
23
-
-
0027960058
-
Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus
-
Lertora JJ, Rege AB, Greenspan DL, et al. Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus. Clin Pharmacol Ther 1994;56:272-278. (Pubitemid 24323918)
-
(1994)
Clinical Pharmacology and Therapeutics
, vol.56
, Issue.3
, pp. 272-278
-
-
Lertora, J.J.L.1
Rege, A.B.2
Greenspan, D.L.3
Akula, S.4
George, W.J.5
Hyslop Jr., N.E.6
Agrawal, K.C.7
-
24
-
-
79955909767
-
Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: A retrospective case control study
-
Okulicz JF, Grandits GA, French JA, et al. Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study. AIDS Res Ther 2011;8:18.
-
(2011)
AIDS Res Ther
, vol.8
, pp. 18
-
-
Okulicz, J.F.1
Grandits, G.A.2
French, J.A.3
-
25
-
-
33745098387
-
Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir
-
Bates DE, Herman RJ. Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir. Ann Pharmacother 2006;40:1190 -1195.
-
(2006)
Ann Pharmacother
, vol.40
, pp. 1190-1195
-
-
Bates, D.E.1
Herman, R.J.2
-
26
-
-
40449118055
-
Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject
-
Bonora S, Calcagno A, Fontana S, et al. Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject. Clin Infect Dis 2007;45:1654 -1655.
-
(2007)
Clin Infect Dis
, vol.45
, pp. 1654-1655
-
-
Bonora, S.1
Calcagno, A.2
Fontana, S.3
-
27
-
-
0034495527
-
Carbamazepine toxicity after starting combination antiretroviral therapy including ritonavir and efavirenz
-
DOI 10.1097/00002030-200012010-00022
-
Burman W, Orr L. Carbamazepine toxicity after starting combination antiretroviral therapy including ritonavir and efavirenz. AIDS 2000;14:2793-2794. (Pubitemid 32118735)
-
(2000)
AIDS
, vol.14
, Issue.17
, pp. 2793-2794
-
-
Burman, W.1
Orr, L.2
-
28
-
-
0242660076
-
Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human
-
Cazali N, Tran A, Treluyer JM, et al. Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human. Br J Clin Pharmacol 2003;56:526 -536.
-
(2003)
Br J Clin Pharmacol
, vol.56
, pp. 526-536
-
-
Cazali, N.1
Tran, A.2
Treluyer, J.M.3
-
29
-
-
7244238106
-
Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults
-
DOI 10.1128/AAC.48.11.4328-4331.2004
-
DiCenzo R, Peterson D, Cruttenden K, et al. Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother 2004;48:4328-4331. (Pubitemid 39434894)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.11
, pp. 4328-4331
-
-
DiCenzo, R.1
Peterson, D.2
Cruttenden, K.3
Morse, G.4
Riggs, G.5
Gelbard, H.6
Schifitto, G.7
-
30
-
-
0033802318
-
Protease inhibitor-induced carbamazepine toxicity
-
Garcia A, Ibarra A, Etessam J, et al. Protease inhibitor-induced carbamazepine toxicity. Clin Neuropharmacol 2000;23:216 -218.
-
(2000)
Clin Neuropharmacol
, vol.23
, pp. 216-218
-
-
Garcia, A.1
Ibarra, A.2
Etessam, J.3
-
31
-
-
0032983746
-
A generalized seizure following initiation of nelfinavir in a patient with human immunodeficiency virus type 1 infection, suspected due to interaction between nelfinavir and phenytoin
-
Honda M, Yasuoka A, Aoki M, Oka S. A generalized seizure following initiation of nelfinavir in a patient with human immunodeficiency virus type 1 infection, suspected due to interaction between nelfinavir and phenytoin. Intern Med 1999;38:302-303. (Pubitemid 29254524)
-
(1999)
Internal Medicine
, vol.38
, Issue.3
, pp. 302-303
-
-
Honda, M.1
Yasuoka, A.2
Aoki, M.3
Oka, S.4
-
32
-
-
0034127381
-
Carbamazepine-indinavir interaction causes antiretroviral therapy failure
-
Hugen PW, Burger DM, Brinkman K, et al. Carbamazepine-indinavir interaction causes antiretroviral therapy failure. Ann Pharmacother 2000;34:465- 470.
-
(2000)
Ann Pharmacother
, vol.34
, pp. 465-470
-
-
Hugen, P.W.1
Burger, D.M.2
Brinkman, K.3
-
33
-
-
0033917785
-
Potential interaction between ritonavir and carbamazepine
-
Kato Y, Fujii T, Mizoguchi N, et al. Potential interaction between ritonavir and carbamazepine. Pharmacotherapy 2000;20:851- 854.
-
(2000)
Pharmacotherapy
, vol.20
, pp. 851-854
-
-
Kato, Y.1
Fujii, T.2
Mizoguchi, N.3
-
34
-
-
85171927964
-
A two-way drug interaction between lopinavir/ritonavir and phenytoin
-
Abstract 535
-
Lim ML, Min SS, Eron JJ, et al. A two-way drug interaction between lopinavir/ritonavir and phenytoin. In: Proceedings from the 10th Conference on Retroviruses and Opportunistic Infections; Feb 10-14, 2003; Boston, MA. Abstract 535.
-
Proceedings from the 10th Conference on Retroviruses and Opportunistic Infections; Feb 10-14, 2003; Boston, MA
-
-
Lim, M.L.1
Min, S.S.2
Eron, J.J.3
-
36
-
-
0034480878
-
Interaccion Indinavir-Fenitoina en un paciente VIH+: A proposito de un caso
-
Olmedilla ML, Fernandez AH, Merino GC. Interaccion Indinavir-Fenitoina en un paciente VIH+: a proposito de un caso. Farm Hosp 2000;24:406-407.
-
(2000)
Farm Hosp
, vol.24
, pp. 406-407
-
-
Olmedilla, M.L.1
Fernandez, A.H.2
Merino, G.C.3
-
37
-
-
32344438918
-
Possible interaction between lopinavir/ritonavir and valproic acid bipolar
-
DOI 10.1345/aph.1G418
-
Sheehan NL, Brouillette MJ, Delisle MS, Allan J. Possible interaction between lopinavir/ritonavir and valproic acid exacerbates bipolar disorder. Ann Pharmacother 2006;40:147-150. (Pubitemid 43221489)
-
(2006)
Annals of Pharmacotherapy
, vol.40
, Issue.1
, pp. 147-150
-
-
Sheehan, N.L.1
Brouillette, M.-J.2
Delisle, M.-S.3
Allan, J.4
-
38
-
-
33746752084
-
Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects
-
van der Lee MJ, Dawood L, ter Hofstede HJ, et al. Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects. Clin Pharmacol Ther 2006;80:159 -168.
-
(2006)
Clin Pharmacol Ther
, vol.80
, pp. 159-168
-
-
Van Der Lee, M.J.1
Dawood, L.2
Ter Hofstede, H.J.3
-
39
-
-
3342927541
-
Coadministration of lopinavir/ ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction
-
Lim ML, Min SS, Eron JJ, et al. Coadministration of lopinavir/ ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction. J Acquir Immune Defic Syndr 2004;36:1034 -1040.
-
(2004)
J Acquir Immune Defic Syndr
, vol.36
, pp. 1034-1040
-
-
Lim, M.L.1
Min, S.S.2
Eron, J.J.3
-
40
-
-
0037169269
-
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia
-
DOI 10.1097/00002030-200201250-00009
-
Deeks SG, Barbour JD, Grant RM, Martin JN. Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia. AIDS 2002;16:201-207. (Pubitemid 34118567)
-
(2002)
AIDS
, vol.16
, Issue.2
, pp. 201-207
-
-
Deeks, S.G.1
Barbour, J.D.2
Grant, R.M.3
Martin, J.N.4
|